Bulletin
Investor Alert

New York Markets Close in:

Regeneron Pharmaceuticals Inc.

NAS: REGN

GO
/marketstate/country/us

Market open

/zigman2/quotes/203149337/composite

$

613.40

Change

-0.98 -0.16%

Volume

Volume 340,957

Jan 21, 2022, 12:59 p.m.

Real time quotes

/zigman2/quotes/203149337/composite

Previous close

$ 614.38

$ 613.40

Change

-0.98 -0.16%

Day low

Day high

$610.88

$623.98

Open
Open: 615.80

52 week low

52 week high

$441.00

$686.62

Open

Market cap

$66.09B

Average volume

692,590

P/E ratio

9.81

Rev. per Employee

$1.48M

EPS

62.63

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/regn

MarketWatch News on REGN

  1. Glaxo and Vir Sell 600,000 Covid Antibody Doses to U.S.

    9:02 a.m. Jan. 11, 2022

    - Josh Nathan-Kazis

  2. Regeneron Pharmaceuticals downgraded to underperform from neutral at BofA Securities

    11:26 a.m. Jan. 5, 2022

    - Tomi Kilgore

  3. Tesla Gets 2022 Off to a Fast Start

    7:29 a.m. Jan. 3, 2022

  4. Omicron may sideline two leading drugs used to treat COVID-19

    5:26 p.m. Dec. 19, 2021

    - Associated Press

  5. Stock Market Jitters Continue Over Covid. It's Too Early to Panic.

    9:57 a.m. Nov. 30, 2021

    - Josh Nathan-Kazis

  6. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/regn

Other News on REGN

  1. ASLAN (ASLN) Starts Phase IIb Study in Atopic Dermatitis

    10:55 a.m. Today

    - Zacks.com

  2. Regeneron (REGN) Rides on Solid Product Portfolio: Should You Buy?

    10:19 a.m. Today

    - Zacks.com

  3. GlaxoSmithKline Racing to Provide Only Effective Covid-19 Antibody Treatment

    8:00 a.m. Today

    - Denise Roland

  4. Sanofi (SNY) 2nd Dupixent Prurigo Nodularis Study Meets Goal (Revised)

    12:06 a.m. Today

    - Zacks.com

  5. Regeneron (REGN)/Sanofi's Libtayo sBLA Accepted by the FDA

    10:41 a.m. Jan. 20, 2022

    - Zacks.com

  6. Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan

    10:39 a.m. Jan. 20, 2022

    - Zacks.com

  7. 11 Good And 4 Bad Reasons To Keep Holding ARK Invest

    3:42 p.m. Jan. 18, 2022

    - Seeking Alpha

  8. 5 ROE Stocks to Buy as Q4 Earnings Witness Shaky Start

    9:10 a.m. Jan. 18, 2022

    - Zacks.com

  9. IHF: Healthcare Dashboard For January

    4:48 a.m. Jan. 18, 2022

    - Seeking Alpha

  10. Dodge & Cox Comments on Regeneron Pharmaceuticals

    5:04 p.m. Jan. 17, 2022

    - GuruFocus.com

  11. Dodge & Cox Global Stock Fund's 4th-Quarter Commentary

    4:55 p.m. Jan. 17, 2022

    - GuruFocus.com

  12. Dodge & Cox Stock Fund's 4th-Quarter Commentary

    4:29 p.m. Jan. 17, 2022

    - GuruFocus.com

  13. Pfizer's (PFE) Cibinqo Gets FDA Nod for Atopic Dermatitis

    9:20 a.m. Jan. 17, 2022

    - Zacks.com

  14. Loading more headlines...
/news/pressrelease/company/us/regn

Press Releases on REGN

  1. How To Trade Regeneron Pharmaceuticals REGN

    11:04 a.m. Jan. 18, 2022

    - Stock Traders Daily

  2. Nasdaq 100 Movers: PTON, VRTX

    10:25 a.m. Jan. 10, 2022

    - MarketNewsVideo.com

  3. Regeneron Pharmaceuticals REGN Technical Analysis

    8:05 p.m. Dec. 29, 2021

    - Stock Traders Daily

  4. Regeneron Pharmaceuticals REGN Buy and Sell Signals

    12:41 a.m. Dec. 20, 2021

    - Stock Traders Daily

  5. Regeneron at Work on Fighting Omicron

    9:42 a.m. Dec. 16, 2021

    - Baystreet.ca

  6. Nasdaq 100 Movers: ALGN, PTON

    12:01 p.m. Dec. 13, 2021

    - MarketNewsVideo.com

  7. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.